Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.
Press releases published on August 4, 2025
Food Safety Testing Market: Future Demand and Top Key Players Analysis | 2029
EIN Presswire
·
August 4, 2025
The Business Research Company's Food Safety Testing Global Market Report-Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 4, 2025 /EINPresswire.com/ -- "Get 30% Off All Global Market Reports With Code …
Fish Powder Market to Reach $12.1 Billion by 2029 with 6.5% CAGR
EIN Presswire
·
August 4, 2025
The Business Research Company’s Fish Powder Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 4, 2025 /EINPresswire.com/ -- Get 30% Off All Global Market Reports With Code …
Aerogel Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
EIN Presswire
·
August 4, 2025
The Business Research Company's Aerogel Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 4, 2025 /EINPresswire.com/ -- Get 30% Off All Global Market Reports With Code ONLINE30 …
Activated Carbon Market to Reach USD $13.85 Million by 2029 at 14.4% CAGR
EIN Presswire
·
August 4, 2025
The Business Research Company's Activated Carbon Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 4, 2025 /EINPresswire.com/ -- "Get 30% Off All Global Market Reports With Code …
Customized Premixes Market Size Worth $2.97 Billion by 2029 - Exclusive Report by The Business Research Company
EIN Presswire
·
August 4, 2025
The Business Research Company's Customized Premixes Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 4, 2025 /EINPresswire.com/ -- How Much Is The Customized Premixes Market …
Acrylic Powder Coating Market to Reach $1.98 Billion by 2029 with 5.5% CAGR
EIN Presswire
·
August 4, 2025
The Business Research Company's Acrylic Powder Coating Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 4, 2025 /EINPresswire.com/ -- "Get 30% Off All Global Market Reports …
Aerosol Market to Grow at 6.4% CAGR from 2025-2029
EIN Presswire
·
August 4, 2025
The Business Research Company’s Aerosol Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, August 4, 2025 /EINPresswire.com/ -- What Is The Aerosol Market Size And Growth? Recent years have …
Bioequivalence Studies Market anticipated to surpass US$1,253.345 million by 2030 at a CAGR of 7.49%
EIN Presswire
·
August 4, 2025
The bioequivalence studies market is anticipated to grow at a CAGR of 7.49% from US$873.352 million in 2025 to US$1,253.345 million by 2030. NEW YORK, NY, UNITED STATES, August 4, 2025 /EINPresswire.com/ -- According to a new study published by …
Cell Line Development Market projected to achieve a CAGR of 12.73% to reach US$8.719 billion by 2030
EIN Presswire
·
August 4, 2025
The cell line development market is anticipated to grow at a CAGR of 12.73% from US$5.359 billion in 2025 to US$8.719 billion by 2030. NEW YORK, NY, UNITED STATES, August 4, 2025 /EINPresswire.com/ -- According to a new study published by Knowledge …
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB
GlobeNewswire
·
August 4, 2025
- Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA LUMPUR, Malaysia, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a …
iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market
GlobeNewswire
·
August 4, 2025
WOBURN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers …
WeightWatchers Reschedules Second Quarter 2025 Earnings Release and Conference Call to Finalize Fresh Start Accounting Adoption in Connection with Emergence
GlobeNewswire
·
August 4, 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) reschedules its earnings release and conference call for the quarterly period ended June 30, 2025, to finalize its Fresh Start …
Regional Health Properties, Inc. and SunLink Health Systems, Inc. Announce Receipt of Shareholder Approvals for Merger
GlobeNewswire
·
August 4, 2025
Atlanta, GA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) and SunLink Health Systems, Inc. (“SunLink”) (NYSE American: SSY) jointly announced today that, at special meetings of their …
Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results
GlobeNewswire
·
August 4, 2025
EDEN PRAIRIE, Minn., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 8, 2025, …
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 4, 2025
DURHAM, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it issued grants of employment inducement awards to Anshul Thakral, the Company’s recently …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 4, 2025
SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)
GlobeNewswire
·
August 4, 2025
LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic™ (linvoseltamab-gcpt), which has been has granted …
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
GlobeNewswire
·
August 4, 2025
Cellectis to host an Investor R…
Cellectis publie ses résultats financiers du deuxième trimestre 2025 et une mise à jour de ses activités
GlobeNewswire
·
August 4, 2025
Cellectis organise un R…
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
GlobeNewswire
·
August 4, 2025
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and will hold a conference call to discuss the …